The 16.1% gross margin remains structurally low, reflecting the company's role as an integrator rather than a proprietary component maker. The swing in operating margin from -27.3% to 4.6% within four quarters underscores extreme sensitivity to volume, as fixed manufacturing overhead is absorbed only at higher revenue levels. Net margin turned positive at 1.3% in 2026Q2, but the prior quarter's -3.4% and the 2025Q2's -31.2% highlight the volatility from non-operating items, likely including impairment charges. Investors should monitor whether the recent operating leverage can persist as revenue growth normalizes.

The ten-quarter trend shows ROIC oscillating between 0.7% and 1.8% since 2024Q1, with a severe dip to -9.0% in 2025Q2, likely due to a goodwill impairment that eroded equity. The recent improvement is driven by margin recovery rather than asset efficiency, as asset turnover has remained flat around 0.3x. ROE of 1.2% in 2026Q2 is positive but still negligible, and the negative ROE of -21.1% in 2025Q2 reflects the equity base reduction from impairments and buybacks. The company is not yet compounding returns; it is merely recovering from a trough, and sustained improvement will require either higher margins or better asset utilization.

DIO increased from 86 days in 2024Q1 to 93 days in 2026Q2, suggesting that inventory is building faster than sales, which is concerning given the custom nature of the products and the risk of obsolescence. DSO improved to 31 days from 35 days, reflecting better receivables collection, while DPO rose to 47 days, indicating the company is taking longer to pay suppliers, which may strain relationships. The net effect is a CCC that has expanded by five days year-over-year, consuming cash at a time when operating cash flow is already negative. This working capital build is a key reason why free cash flow turned sharply negative in 2026Q2, and investors should monitor whether inventory levels normalize as demand stabilizes.

Total debt increased to $775.9M, and the D/E ratio now exceeds that of peers like Ichor (0.24) and Entegris (0.98), indicating a heavier reliance on debt financing. The interest coverage ratio of 28.27 in 2026Q2 is a dramatic improvement from 1.58 in 2026Q1, but this is driven by the spike in operating income; in 2025Q2, coverage was negative at -14.18. The D/EBITDA ratio of 24.95 remains elevated, suggesting that EBITDA is still low relative to debt, and any downturn could quickly erode coverage. The company's leverage appears to be funding growth, but the thin margins leave little room for error, and refinancing risk may emerge if earnings do not sustain.

The current ratio of 2.73 appears healthy, but the quick ratio of 1.25 reveals that inventory constitutes a significant portion of current assets, and its liquidation value may be uncertain given the custom nature of the products. Cash and equivalents of $255.9M provide a buffer, but the negative free cash flow of -$57.3M in 2026Q2 suggests the company is consuming cash to fund working capital. Under a severe demand shock, the company could face liquidity pressure if inventory becomes difficult to sell and customers delay payments. The adequate but not fortress-like liquidity position warrants monitoring, especially given the high leverage and thin margins.

Compared to peers, UCTT's EV/EBITDA of 36.84 is higher than Entegris's 20.35 and MKSI's 27.08, but this is distorted by UCTT's depressed EBITDA; on a forward basis, the multiple drops to 24.56, closer to the group. The P/B of 5.04 is above Ichor's 3.52 but below MKSI's 7.59 and ENTG's 5.85, suggesting the market assigns a moderate premium to its asset base. The negative trailing P/E of -21.81 reflects the recent losses, while the forward P/E of 27.57 implies the market expects a significant earnings recovery. The discount to component-heavy peers like MKSI and ENTG appears structural, given UCTT's lower gross margins and reliance on assembly, but the Services segment may justify a re-rating if it grows.